ICM
HLF icon

Invenomic Capital Management’s Herbalife HLF Stock Holding History

Invenomic Capital Management’s Portfolio HLF Stock Details HLF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-89,773
Closed -$1.32M – 131
2026
Q1 		$1.32M Sell
89,773
-678,258
-88% -$11.1M 0.06% 136
2025
Q4 		$9.9M Buy
768,031
+347,401
+83% +$3.68M 0.46% 69
2025
Q3 		$3.55M Buy
+420,630
New +$3.97M 0.17% 115
2022
Q2 		– Sell
-258,888
Closed -$6.48M – 165
2022
Q1 		$6.48M Buy
258,888
+170,002
+191% +$6.65M 0.69% 43
2021
Q4 		$3.64M Buy
88,886
+1,794
+2% +$74.7K 0.78% 49
2021
Q3 		$3.69M Buy
87,092
+9,141
+12% +$452K 1.2% 28
2021
Q2 		$4.11M Buy
77,951
+44,023
+130% +$2.19M 0.98% 21
2021
Q1 		$1.5M Buy
+33,928
New +$1.67M 0.34% 58

Other funds holding HLF

BG
Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ROIC
Route One Investment Company San Francisco, California $2.49B AUM 10.92% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SP
Solel Partners Boston, Massachusetts $588M AUM 14.47% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invenomic Capital Management's HLF Position: Q2 2026 in Review

Invenomic Capital Management sold out of Herbalife (HLF) in Q2 2026, closing a stake of 89,773 shares — an estimated $1.32M sold.

Invenomic Capital Management first reported a position in HLF in Q1 2021 and held it in 8 quarters. The position peaked at $9.9M in Q4 2025. 234 funds tracked by Wall St. Rank hold HLF as of Q2 2026.

  • Invenomic Capital Management reported no remaining Herbalife position as of Q2 2026 after selling out during the quarter.
  • Invenomic Capital Management sold 89,773 Herbalife shares in Q2 2026, an estimated $1.32M.
  • Invenomic Capital Management first reported a position in Herbalife in Q1 2021 and held it in 8 quarters.
  • Invenomic Capital Management's Herbalife position peaked at $9.9M in Q4 2025.
  • 234 funds tracked by Wall St. Rank held Herbalife as of Q2 2026.

Based on Invenomic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.